NCT02850718View on ClinicalTrials.gov

A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer

PHASE3CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Erectile Dysfunction

Interventions

DRUG

Sublingual Sildenafil

50 mg sildenafil sublingual wafer.

DRUG

Oral Sildenafil

50 mg oral sildenafil (Viagra)

Trial Locations (1)

6009

Linear Clinical Research, Perth

Sponsors

Collaborators (1)

Linear Clinical Research

All Listed Sponsors

collaborator

Linear Clinical Research

INDUSTRY

lead

iX Biopharma Ltd.

OTHER